143 related articles for article (PubMed ID: 34604685)
21. Activation of P2X(7) receptors induced [(3)H]GABA release from the RBA-2 type-2 astrocyte cell line through a Cl(-)/HCO(3)(-)-dependent mechanism.
Wang CM; Chang YY; Kuo JS; Sun SH
Glia; 2002 Jan; 37(1):8-18. PubMed ID: 11746779
[TBL] [Abstract][Full Text] [Related]
22. Functional characterization of the P2X(4) receptor orthologues.
Jones CA; Chessell IP; Simon J; Barnard EA; Miller KJ; Michel AD; Humphrey PP
Br J Pharmacol; 2000 Jan; 129(2):388-94. PubMed ID: 10694247
[TBL] [Abstract][Full Text] [Related]
23. Sensitization by extracellular Ca(2+) of rat P2X(5) receptor and its pharmacological properties compared with rat P2X(1).
Wildman SS; Brown SG; Rahman M; Noel CA; Churchill L; Burnstock G; Unwin RJ; King BF
Mol Pharmacol; 2002 Oct; 62(4):957-66. PubMed ID: 12237343
[TBL] [Abstract][Full Text] [Related]
24. Expression of P2X receptors in the rat anterior pituitary.
Zhao W; Zhang Y; Ji R; Knight GE; Burnstock G; Yuan H; Xiang Z
Purinergic Signal; 2020 Mar; 16(1):17-28. PubMed ID: 31823189
[TBL] [Abstract][Full Text] [Related]
25. Two different inhibitory effects of pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid on adenosine diphosphate-induced human platelet aggregation.
Windscheif U; Radziwon P; Breddin HK; Bäumert HG; Lambrecht G; Mutschler E
Arzneimittelforschung; 1995 Sep; 45(9):994-7. PubMed ID: 7488321
[TBL] [Abstract][Full Text] [Related]
26. Medicinal chemistry of P2X receptors: agonists and orthosteric antagonists.
Lambertucci C; Dal Ben D; Buccioni M; Marucci G; Thomas A; Volpini R
Curr Med Chem; 2015; 22(7):915-28. PubMed ID: 25515515
[TBL] [Abstract][Full Text] [Related]
27. Trinitrophenyl-substituted nucleotides are potent antagonists selective for P2X1, P2X3, and heteromeric P2X2/3 receptors.
Virginio C; Robertson G; Surprenant A; North RA
Mol Pharmacol; 1998 Jun; 53(6):969-73. PubMed ID: 9614197
[TBL] [Abstract][Full Text] [Related]
28. Hetero-oligomeric assembly of P2X receptor subunits. Specificities exist with regard to possible partners.
Torres GE; Egan TM; Voigt MM
J Biol Chem; 1999 Mar; 274(10):6653-9. PubMed ID: 10037762
[TBL] [Abstract][Full Text] [Related]
29. Cross-Talk between P2X and NMDA Receptors.
Rodriguez L; Yi C; Chu C; Duriez Q; Watanabe S; Ryu M; Reyes B; Asatryan L; Boué-Grabot E; Davies D
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003406
[TBL] [Abstract][Full Text] [Related]
30. Identification and characterization of a selective allosteric antagonist of human P2X4 receptor channels.
Ase AR; Honson NS; Zaghdane H; Pfeifer TA; Séguéla P
Mol Pharmacol; 2015 Apr; 87(4):606-16. PubMed ID: 25597706
[TBL] [Abstract][Full Text] [Related]
31. Discovery and Structure Relationships of Salicylanilide Derivatives as Potent, Non-acidic P2X1 Receptor Antagonists.
Tian M; Abdelrahman A; Baqi Y; Fuentes E; Azazna D; Spanier C; Densborn S; Hinz S; Schmid R; Müller CE
J Med Chem; 2020 Jun; 63(11):6164-6178. PubMed ID: 32345019
[TBL] [Abstract][Full Text] [Related]
32. Discovery of potent competitive antagonists and positive modulators of the P2X2 receptor.
Baqi Y; Hausmann R; Rosefort C; Rettinger J; Schmalzing G; Müller CE
J Med Chem; 2011 Feb; 54(3):817-30. PubMed ID: 21207957
[TBL] [Abstract][Full Text] [Related]
33. Oxidized ATP decreases beta-actin expression and intracellular superoxide concentrations in RBA-2 type-2 astrocytes independently of P2X7 receptor.
Chen HB; Lin YH; Sun SH
Eur J Pharmacol; 2006 Nov; 550(1-3):1-7. PubMed ID: 17020759
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of ATP-gated P2X receptors in DRG between chronic neuropathic pain and visceralgia rat models.
Chen L; Liu YW; Yue K; Ru Q; Xiong Q; Ma BM; Tian X; Li CY
Purinergic Signal; 2016 Mar; 12(1):79-87. PubMed ID: 26531254
[TBL] [Abstract][Full Text] [Related]
35. Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states.
Donnelly-Roberts DL; Jarvis MF
Br J Pharmacol; 2007 Jul; 151(5):571-9. PubMed ID: 17471177
[TBL] [Abstract][Full Text] [Related]
36. P2X receptors: New players in cancer pain.
Franceschini A; Adinolfi E
World J Biol Chem; 2014 Nov; 5(4):429-36. PubMed ID: 25426266
[TBL] [Abstract][Full Text] [Related]
37. P2X7 receptor inhibition by 2-amino-3-aryl-1,4-naphthoquinones.
de Luna Martins D; Borges AA; E Silva NADA; Faria JV; Hoelz LVB; de Souza HVCM; Bello ML; Boechat N; Ferreira VF; Faria RX
Bioorg Chem; 2020 Nov; 104():104278. PubMed ID: 33010623
[TBL] [Abstract][Full Text] [Related]
38. [Effects of lappaconitine on pain and inflammatory response of severely burned rats and the mechanism].
Yang CL; Wei ZR; Zhang TH; Zeng XQ; Wu BH
Zhonghua Shao Shang Za Zhi; 2017 Jun; 33(6):374-380. PubMed ID: 28648042
[No Abstract] [Full Text] [Related]
39. Role of the purinergic P2X receptors in osteoclast pathophysiology.
Jørgensen NR
Curr Opin Pharmacol; 2019 Aug; 47():97-101. PubMed ID: 30954934
[TBL] [Abstract][Full Text] [Related]
40. Involvement of temporomandibular joint P2X3 and P2X2/3 receptors in carrageenan-induced inflammatory hyperalgesia in rats.
Teixeira JM; Oliveira MC; Nociti FH; Clemente-Napimoga JT; Pelegrini-da-Silva A; Parada CA; Tambeli CH
Eur J Pharmacol; 2010 Oct; 645(1-3):79-85. PubMed ID: 20558155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
